Replies to post #6837 on Halozyme Therapeutics Inc (HALO)

[Fred Kadiddlehopper]

Agreed and I wonder what the text of the recent analyst reports actually says about all of these concerns. At least two (Wells and JMP) have PTs at $58 and $55 respectively (per Benzinga). How do they address the rosy PT outlook in the face of these real uncertainties?